New Finding Suggests Safe Surgical Margins When Removing
THURSDAY, Oct. 21 (HealthDay News) -- A new study suggests that
in women undergoing breast-conserving surgery, removing at least 2
millimeters of healthy tissue in addition to a cancerous breast
tumor is enough to lower the risk of residual cancer.
Surgeons disagree about how much of a "free margin" around a
tumor is ideal, according to the study, which appears online in the
November issue of
IJCP, the International Journal of Clinical Practice. In the United Kingdom, about two-thirds of surgeons surveyed said they prefer a margin of 2 millimeters or more, while nearly a quarter favor removing only 1 millimeter.
"The issue is that whenever you take a lump out of someone's breast, you want to have some normal tissue around the entire malignancy. That's how the surgeon can make the statement that 'I think I got the whole thing,'" said Dr. Otis Brawley, chief medical officer of the American Cancer Society.
Surgeons often perform a procedure again if they don't think the
margins are large enough, Brawley said.
In the new study, researchers from Good Hope Hospital in West
Midland, U.K., examined the medical records of 303 breast cancer
patients undergoing breast conservation therapy to remove a
cancerous lump. They found that 44 percent underwent follow-up
surgery because the margins around the tumors were less than 5
millimeters and considered too small. Upon examination of the
excised tissues, however, only about 2 percent of those with
margins of 2 millimeters or more showed signs of residual
This meant that with a free margin of 2 millimeters or more, 98
percent of the patients showed no signs of residual cancer, the
In addition, they found that the amount of residual disease
decreased as the margin increased: 35.3 percent of the women who
underwent surgery for invasive breast cancer had residual cancer
with no margin, compared to 2.4 percent with a margin of more than
"Our results clearly show a relationship between the width of the free margin and the likelihood of finding residual disease at further surgery," the researchers wrote. "To minimize the risk of residual disease, we would recommend aiming for a free margin from invasive tumor of 2 millimeters."
However, the study authors noted that the findings did not apply
to women with a precancerous condition known as ductal carcinoma in
situ (DCIS). One-third of the patients with DCIS had residual
disease even with a free margin up to 5 millimeters. "The
equivalent free margin for DCIS remains unknown," they wrote.
Brawley said surgeons may someday embrace 2-millimeter margins
around malignant tumors and perform fewer follow-up surgeries as a
result. "But it'll be a while before people gravitate to it," he
The U.S. National Library of Medicine has more on
Copyright © 2010
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.